A review of traditional Chinese medicine Curcumae Rhizoma for treatment of glioma.

International review of neurobiology Pub Date : 2023-01-01 Epub Date: 2023-09-19 DOI:10.1016/bs.irn.2023.07.004
Qijia Tan, Jiamin Lu, Jingtong Liang, Yuchen Zhou, Chunrong Yang, Zhiqiang Zhang, Cong Li
{"title":"A review of traditional Chinese medicine Curcumae Rhizoma for treatment of glioma.","authors":"Qijia Tan,&nbsp;Jiamin Lu,&nbsp;Jingtong Liang,&nbsp;Yuchen Zhou,&nbsp;Chunrong Yang,&nbsp;Zhiqiang Zhang,&nbsp;Cong Li","doi":"10.1016/bs.irn.2023.07.004","DOIUrl":null,"url":null,"abstract":"<p><p>Glioma is the most common primary central nervous tumor and its malignant and high recurrence rate are seriously threatening patient's life. The prognosis of glioma patients is still poor with a variety of modern treatments. Traditional Chinese medicine (TCM) is widely used in the adjuvant treatment or alternative medicine of glioma. Curcumae Rhizoma is one of the most commonly used in traditional Chinese medicine prescriptions for its anti-tumor characteristics. There are also many studies that reveals the anti-tumor effect of its active ingredients and some of which have been made into drugs and have been used in clinical practice. This review summarizes the new research progress on Curcumae Rhizoma for the treatment of glioma in recent years.</p>","PeriodicalId":94058,"journal":{"name":"International review of neurobiology","volume":"172 ","pages":"303-319"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International review of neurobiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/bs.irn.2023.07.004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/9/19 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Glioma is the most common primary central nervous tumor and its malignant and high recurrence rate are seriously threatening patient's life. The prognosis of glioma patients is still poor with a variety of modern treatments. Traditional Chinese medicine (TCM) is widely used in the adjuvant treatment or alternative medicine of glioma. Curcumae Rhizoma is one of the most commonly used in traditional Chinese medicine prescriptions for its anti-tumor characteristics. There are also many studies that reveals the anti-tumor effect of its active ingredients and some of which have been made into drugs and have been used in clinical practice. This review summarizes the new research progress on Curcumae Rhizoma for the treatment of glioma in recent years.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
中药莪术治疗胶质瘤的研究进展。
胶质瘤是最常见的原发性中枢神经肿瘤,其恶性和高复发率严重威胁患者的生命。神经胶质瘤患者的预后仍然很差,采用了各种现代治疗方法。中医药广泛应用于胶质瘤的辅助治疗或替代药物治疗。姜黄以其抗肿瘤的特点,成为中药方剂中最常用的药材之一。也有许多研究揭示了其活性成分的抗肿瘤作用,其中一些已被制成药物并用于临床实践。综述了近年来莪术治疗胶质瘤的研究进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A general clinical overview of the non-motor symptoms in Parkinson's disease: Neuropsychiatric symptoms. Executive dysfunction and cognitive decline, a non-motor symptom of Parkinson's disease captured in animal models. Insight gained from using animal models to study pain in Parkinson's disease. Investigating affective neuropsychiatric symptoms in rodent models of Parkinson's disease. Macro and micro-sleep dysfunctions as translational biomarkers for Parkinson's disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1